Coronavirus disease (COVID-19) is an infectious disease caused by novel type coronavirus (SARS-CoV-2). In most cases the disease will cause mild or moderate respiratory symptoms and those infected will recover without any special treatment. However, elderly people and people with underlying health conditions, such as asthma and COPD, are considered to be at greater risk of developing severe complications.
It is important to ensure your asthma or COPD is as well managed as possible. Follow your treatment plan and keep taking your usual medications as prescribed. The use of corticosteroids has not been shown to worsen the infection or its symptoms. In case of uncertainty, consult your doctor, nurse, pharmacist or your local health authority for more advice.
Coronavirus is spread from person to person via respiratory droplets which are released when someone with the disease coughs, sneezes or exhales. Hard and soft surfaces can also harbor these droplets which can be a source of infection. The best way to avoid infection is through social distancing, especially crowds, and staying away from public areas. Protect yourself by washing your hands frequently with soap for 20 seconds at a time or use alcohol-based rubs and avoid touching your face with unwashed hands.
According to the World Health Organization (WHO), being well informed about COVID-19 is the best way to prevent and slow the transmission of the disease. Local and global guidelines can change rapidly when new information about coronavirus and its transmission becomes available. Seek more info regularly by following the news and websites of international health agencies (e.g., WHO or ECDC) and your local health authorities.
In case you have asthma or COPD and experience symptoms such as fever, cough, shortness of breath, muscle pain and tiredness, do not hesitate to contact your health care provider.
World Health Organization (WHO). https://www.who.int/health-topics/coronavirus, accessed March 24, 2020.
European Centre for Disease Prevention and Control (ECDC). https://www.ecdc.europa.eu/en/novel-coronavirus-china, accessed March 24, 2020.
Global Initiative for Asthma. https://ginasthma.org/recommendations-for-inhaled-asthma-controller-medications/, accessed March 24, 2020.
Global Initiative for Chronic Obstructive Lung Disease. https://goldcopd.org/gold-covid-19-guidance/, accessed March 24, 2020.
Orion invests in research and development of treatment options for people with asthma and COPD while also developing the design and usability of the Easyhaler® inhaler device platform. The focus is on safety and quality in each step of the product life cycle while taking care of the environment. All aspects of sustainability - social, economic and environmental - are carefully considered in the whole product life cycle. Sustainability is entwined in the whole process from R&D through manufacturing, including patient use and the disposal of old inhalers.